Pubblicazioni

Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells

2021 - MOLECULES

Capozzi, A.; Caissutti, D.; Mattei, V.; Gado, F.; Martellucci, S.; Longo, A.; Recalchi, S.; Manganelli, V.; Riitano, G.; Garofalo, T.; Sorice, M.; Manera, C.; Misasi, R.

Antioxidant modulation of sirtuin 3 during acute inflammatory pain: The ROS control

2020 - PHARMACOLOGICAL RESEARCH

Ilari, S.; Giancotti, L. A.; Lauro, F.; Dagostino, C.; Gliozzi, M.; Malafoglia, V.; Sansone, L.; Palma, E.; Tafani, M.; Russo, M. A.; Tomino, C.; Fini, M.; Salvemini, D.; Mollace, V.; Muscoli, C.

Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150, decreases neuroblastoma tumorigenicity and increases chemosensitivity

2017 - CLINICAL CANCER RESEARCH

Odate, S.; Veschi, V.; Yan, S.; Lam, N.; Woessner, R.; Thiele, C. J.

Epigenetics in medullary thyroid cancer: from pathogenesis to targeted therapy

2016 - RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY

Vitale, Giovanni; Dicitore, Alessandra; Messina, Erika; Sciammarella, Concetta; Faggiano, Antongiulio; Colao, Annamaria